CLICK: Biographical Sketch
Office: Bldg 307 Rm 205
Courses: 4177087-1, 4177993-5, 4177045-1, 4177068-1
Ki-Taek Lim, Ph.D.
Associate Professor, Biosystems Engineering, KNU (home)
Adjunct Professor / Visiting Scholar, Biosystems Engineering, SNU (jointed)
CEO, BIOMECHAGEN CO., LTD. (jointed)
Stem cell-reactor automated system
3D bioprinted drug delivery hydrogel patches
Cell therapeutics based on tissue engineering and regenerative medicine
Cancer therapy based on Bio/Nano-technology applications
NK cell-derived exosome cancer immunotherapy
A simple test kit for the detection of nanoparticles
4D printing for science robotics
Prof. Lim completed his undergraduate degrees in Biosystems Engineering at Konkuk University and an MA in Biomechatronics from Sungkyunkwan University. Ki-Taek continued his doctoral studies in Biosystems Engineering at Seoul National University under the joint supervision of Prof. Jong Hoon Chung. He held a postdoctoral appointment at Dental Research Institute, Seoul National University where he developed high-throughput automated culture platforms via a bioreactor process engineering for enhanced tissue regeneration from stem cells in Prof. Pill-Hoon Choung’s laboratory, plus, he developed nanoparticles as tools to control stem cells in Prof. Jin-Woo Kim’s Bio/Nano-Technology Group, Institute for Nanoscience and Engineering, University of Arkansas, Fayetteville. Ki-Taek joined KNU as an Assistant Professor of Biosystems Engineering in Feb. 2015, with getting along with an Adjunct Professor and a Visiting Scholar at SNU (Seoul National University)
Broadly, research in the Lim group integrates new bioreactor process, optical, and bio/nano-technology tools for application in biology and agricultural engineering. We pioneer the bio-convergence system in biosystems engineering approaches, aiming to enable multi-parametric studies with the power to reveal the workings of natural and engineered biological systems.
Bioreactor Engineering/Automated Bioreactor System: Engineering Parameters in Bioreactor’s Design
Automation and -Robotics for Biological Engineering
Tissue Engineering and Regenerative Medicine
Bioceramics for Bone Tissue Engineering
Stem Cell Culture Technologies & Convergence Engineering based on 3D Printing & Micro-Nano Platforms
Pathogen Detection Systems using fully automated-on site microbiological testing productions.
Technopreneurship & Startup
Founder, Biomechagen Co., Ltd.
Biomechagen is pioneering the development of a new class of specific therapeutic nanoengineering healingforms. Our new technology platform is based on the discovery of exosome functions s to block the immune processes causing immune-mediated diseases. Biomechagen is a privately held biotechnology company focused on the discovery, development and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard-of-care therapies. Biomechagen's initial portfolio is comprised of long-acting antifungal product candidates, exosome-skincare and its healing nanohydrogel patches for the treatment of serious fungal infections. In addition, Biomechagen has developed a proprietary immunotherapy platform, HydrogelBG, designed to create antifungals, antibacterials and antivirals that direct a patient's immune cells to attack and eliminate pathogens that cause infectious disease.
Biomechagenis headquartered in Chuncheon, South Korea.
Synergistic Platforms of Next-Generation